| scholarly article | Q13442814 |
| P356 | DOI | 10.1084/JEM.180.3.933 |
| P8608 | Fatcat ID | release_mmpdarbao5el7ifqlf3dzst2tm |
| P932 | PMC publication ID | 2191652 |
| P698 | PubMed publication ID | 7520476 |
| P5875 | ResearchGate publication ID | 15677583 |
| P50 | author | Francis V. Chisari | Q1424562 |
| Antonio Bertoletti | Q37828529 | ||
| Carlo Ferrari | Q37828540 | ||
| Antonio Costanzo | Q38319077 | ||
| Massimo Levrero | Q67592879 | ||
| P2093 | author name string | A Sette | |
| A Penna | |||
| F Fiaccadori | |||
| M Artini | |||
| T Giuberti | |||
| P2860 | cites work | Structure of the human class I histocompatibility antigen, HLA-A2 | Q24297966 |
| The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides | Q24339477 | ||
| Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV | Q27486078 | ||
| Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb | Q27642080 | ||
| Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition | Q27642083 | ||
| Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle | Q27642184 | ||
| Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution | Q27660465 | ||
| Specificity pockets for the side chains of peptide antigens in HLA-Aw68 | Q27700642 | ||
| The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2 | Q27729917 | ||
| Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition | Q28282470 | ||
| T-cell tolerance: exposure to virus in utero does not cause a permanent deletion of specific T cells | Q33564026 | ||
| Identification of residues necessary for clonally specific recognition of a cytotoxic T cell determinant. | Q33572540 | ||
| Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. | Q34323839 | ||
| T cell memory is short-lived in the absence of antigen | Q36230537 | ||
| Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen | Q36230704 | ||
| Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen | Q36231954 | ||
| Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions | Q36345424 | ||
| HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis | Q36361411 | ||
| Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes | Q36436398 | ||
| Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705. | Q36507341 | ||
| Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. | Q36651995 | ||
| Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. | Q36687045 | ||
| Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens | Q36692634 | ||
| Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo | Q36918873 | ||
| CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity | Q36919192 | ||
| HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen | Q37627780 | ||
| The structure of the antigen-binding groove of major histocompatibility complex class I molecules determines specific selection of self-peptides | Q37640010 | ||
| HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection | Q38319278 | ||
| MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness | Q39576364 | ||
| Protein traffic on the heat shock promoter: parking, stalling, and trucking along | Q40826956 | ||
| Hepatitis B virus genes and their expression in E. coli | Q41200439 | ||
| Cytotoxic T-cell memory without antigen | Q41460535 | ||
| Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells | Q41461980 | ||
| Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule | Q41714857 | ||
| In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific | Q42937027 | ||
| The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen | Q42942101 | ||
| Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis | Q42983469 | ||
| Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. | Q44572777 | ||
| Atomic structure of a human MHC molecule presenting an influenza virus peptide | Q44667197 | ||
| Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells | Q45007765 | ||
| Virus-specific CD8+ T-cell memory determined by clonal burst size | Q45789854 | ||
| Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. | Q45850067 | ||
| Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo | Q45860175 | ||
| The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens | Q59092174 | ||
| Emerging principles for the recognition of peptide antigens by MHC class I molecules | Q67494475 | ||
| The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC | Q68045564 | ||
| Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans | Q69050654 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis B virus | Q6844 |
| hepatitis B | Q6853 | ||
| virology | Q7215 | ||
| patient | Q181600 | ||
| cytotoxicity | Q246181 | ||
| lymphocyte | Q715347 | ||
| P304 | page(s) | 933-943 | |
| P577 | publication date | 1994-09-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope | |
| P478 | volume | 180 |
| Q35225155 | A family cluster of an immune escape variant of hepatitis B virus infecting a mother and her two fully immunized children |
| Q46783012 | A mutant HBs antigen (HBsAg)183-191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients |
| Q37730643 | A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro |
| Q35887509 | A new vaccine escape mutant of hepatitis B virus causes occult infection |
| Q41462634 | Adaptation of the hepatitis B virus core protein to CD8(+) T-cell selection pressure. |
| Q33808561 | Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes |
| Q42947291 | Associations between HLA class I alleles and escape mutations in the hepatitis B virus core gene in New Zealand-resident Tongans |
| Q36364858 | Autoantibodies produced spontaneously by young 1pr mice carry transforming growth factor beta and suppress cytotoxic T lymphocyte responses |
| Q51056253 | CD8(low)CD28(-) T Cells: A Human CD8 T-Suppressor Subpopulation With Alloantigen Specificity Induced by Soluble HLA-A2 Dimer In Vitro. |
| Q42797242 | Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection |
| Q35066642 | Characterization of occult hepatitis B virus infection from blood donors in China |
| Q41755670 | Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection. |
| Q41298896 | Class I HLA-restricted cytotoxic T lymphocyte responses against malaria--elucidation on the basis of HLA peptide binding motifs |
| Q47561111 | Current concepts on immunopathogenesis of hepatitis B virus infection. |
| Q42833094 | Cytotoxic T cell responses against hepatitis B virus polymerase induced by genetic immunization |
| Q45237312 | Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease |
| Q37365416 | Cytotoxic T cells and viral hepatitis |
| Q35895744 | Cytotoxic T-cell-resistant variants arise at early times after infection in C57BL/6 but not in SCID mice infected with a neurotropic coronavirus. |
| Q77488323 | Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo? |
| Q59359697 | Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand |
| Q45746042 | Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection |
| Q45756411 | Distinct patterns of T cell receptor distribution of peripheral blood CD8+ cells during different stages of chronic infection with hepatitis B virus |
| Q37209954 | Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B. |
| Q35851158 | Emergence of virus escape mutants after immunization with epitope vaccine. |
| Q36370173 | Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection |
| Q27006179 | Evaluation of current cancer immunotherapy: hemato-oncology |
| Q46514345 | Flow cytometric quantification of T cell proliferation and division kinetics in woodchuck model of hepatitis B. |
| Q40459585 | Generation of a Novel HLA Class I Transgenic Mouse Model Carrying a Knock-in Mutation at the β2-Microglobulin Locus. |
| Q36532429 | Genetic variation in HBV infection: genotypes and mutants |
| Q35688341 | Genogeography and Immune Epitope Characteristics of Hepatitis B Virus Genotype C Reveals Two Distinct Types: Asian and Papua-Pacific |
| Q39244731 | HBV-specific CD4+ cytotoxic T cells in hepatocellular carcinoma are less cytolytic toward tumor cells and suppress CD8+ T cell-mediated antitumor immunity |
| Q56918262 | Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen |
| Q42991680 | Hepatitis B and C virus variants in long-term immunosuppressed renal transplant patients in Latvia. |
| Q34807240 | Hepatitis B treatment: rational combination chemotherapy based on viral kinetic and animal model studies. |
| Q35763331 | Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection |
| Q37284817 | Hepatitis B virus DNA is more powerful than HBeAg in predicting peripheral T-lymphocyte subpopulations in chronic HBV-infected individuals with normal liver function tests |
| Q40951387 | Hepatitis B virus immunopathology |
| Q27490846 | Hepatitis C Virus (HCV) Sequence Variation Induces an HCV-Specific T-Cell Phenotype Analogous to Spontaneous Resolution |
| Q36883851 | Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection |
| Q36949834 | Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. |
| Q37611853 | Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus |
| Q34022674 | How can the cellular immune response control hepatitis B virus replication? |
| Q36080854 | Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice |
| Q27658413 | Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses |
| Q33939747 | Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection |
| Q34055780 | Immune escape by hepatitis B viruses. |
| Q27485222 | Immune evasion versus recovery after acute hepatitis C virus infection from a shared source |
| Q35837479 | Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus |
| Q53715700 | Immunodominance of cytotoxic T lymphocyte epitopes co-injected in vivo and modulation by interleukin-12. |
| Q37374471 | Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus |
| Q34562294 | Immunology of hepatitis B infection |
| Q36666336 | Immunopathogenesis of hepatitis B virus infection |
| Q35621639 | Immunopathogenesis of hepatitis B. |
| Q33809427 | Immunopathogenesis of hepatitis C virus infection |
| Q29620795 | Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection |
| Q43276074 | Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. |
| Q39606123 | In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb |
| Q33785674 | Infection with cytotoxic T-lymphocyte escape mutants results in increased mortality and growth retardation in mice infected with a neurotropic coronavirus. |
| Q45351930 | Influence of overlapping genes on the evolution of human hepatitis B virus |
| Q33894481 | Intrahepatic T cells in hepatitis B: viral control versus liver cell injury |
| Q37382996 | Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection |
| Q34151071 | Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy |
| Q40612811 | MHC ligands and peptide motifs: first listing |
| Q41681561 | Mechanisms of viral clearance and persistence |
| Q41593993 | Modulation of antigen processing and presentation by persistent virus infections and in tumors |
| Q58808842 | Molecular Variants of the Precore, Core, and Core Promoter Regions of Hepatitis B Virus, and Their Clinical Significance |
| Q28086907 | Mutational escape of CD8+ T cell epitopes: implications for prevention and therapy of persistent hepatitis virus infections |
| Q33812154 | Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity |
| Q33671155 | Naturally occurring variants of hepatitis B virus |
| Q37412564 | Number of mutations within CTL-defined epitopes of the hepatitis B Virus (HBV) core region is associated with HBV disease progression |
| Q59080204 | Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes |
| Q45763494 | Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis |
| Q37267440 | Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load |
| Q27302970 | Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors |
| Q34499902 | Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant |
| Q45356792 | Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection. |
| Q45788252 | Prevalence of precore‐defective mutant of hepatitis B virus in HBV carriers |
| Q33295380 | Protection of hepatocytes from cytotoxic T cell mediated killing by interferon-alpha |
| Q34462097 | Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection. |
| Q90243326 | Restoring, releasing or replacing adaptive immunity in chronic hepatitis B |
| Q77933591 | Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP) |
| Q38121579 | Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation |
| Q34306667 | Selection of and evasion from cytotoxic T cell responses in the central nervous system |
| Q40928716 | Selective mechanisms utilized by persistent and oncogenic viruses to interfere with antigen processing and presentation |
| Q39748086 | Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes |
| Q27470232 | Stealth and cunning: hepatitis B and hepatitis C viruses |
| Q97424006 | T cell antigen discovery |
| Q45739577 | T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection |
| Q24626152 | T cell recognition of weak ligands: roles of signaling, receptor number, and affinity |
| Q28083810 | T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance |
| Q37333937 | T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope |
| Q26774875 | The Role of Immune Cells in Chronic HBV Infection |
| Q36303449 | The hepatitis B virus X gene induces p53-mediated programmed cell death |
| Q44616157 | The intrahepatic immune response during chronic hepatitis B infection can be monitored by the fine-needle aspiration biopsy technique |
| Q41435458 | The role of cytotoxic T lymphocytes in the evolution of genetically stable viruses |
| Q38219409 | The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection |
| Q36368397 | The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection |
| Q37434613 | Transient alteration of T cell fine specificity by a strong primary stimulus correlates with T cell receptor down-regulation |
| Q35160324 | Translation of immunological knowledge into better treatments of chronic hepatitis B. |
| Q46610438 | Tumor-associated carbohydrate antigens: a possible avenue for cancer prevention |
| Q37195244 | Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective. |
| Q38259535 | Update on hepatitis B virus infection |
Search more.